Executive Solution Overview
– ## 3tabledrc.docx **## 3tabledrc.docx** | | | | | | — | — | — | — | | Drug name | **Indication**<br>Target symptoms: state if positive or negative effect<br>Potency (if noted. receptor occupancy if noted ) <br>Neurotransmitter(s) affected | Half-life (T1/2), metabolism (CYP 450 enzyme) | Notable side effects (associate to pathway or NT) |…
Instant Solution Download
.99Immediate access to the full model answer, formatted citations, and rubric breakdown.
Need a Fresh Custom Paper?
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Assignment Prompt & Instructions
– ## 3tabledrc.docx **## 3tabledrc.docx** | | | | | | — | — | — | — | | Drug name | **Indication**<br>Target symptoms: state if positive or negative effect<br>Potency (if noted. receptor occupancy if noted ) <br>Neurotransmitter(s) affected | Half-life (T1/2), metabolism (CYP 450 enzyme) | Notable side effects (associate to pathway or NT) | | **Typical antipsychotics (conventional)** | | Haloperidol | | | | | Thioridazine | | | | | Thiothixene | | | | | Fluphenazine | | | | | Mesoridazine | | | | | Chlorpromazine | | | | | **Atypical antipsychotics (2nd generation)** | | **Pines** | | | | | Olanzapine | | | | | Quetiapine | | | | | Asenapine | | | | | Clozapine | | | | | **Dones** | | | | | Risperidone | | | | | Paliperidone | | | | | Ziprasidone | | | | | Iloperidne | | | | | Lurasidone | | | | | **Two Pips and a Rip** | | | | Aripiprazole | | | | | Brexpiprazole | | | | | Cariprazine | | | | 1. For each medication listed, complete the following: a. Provide indication, target symptoms, potency, and affected neurotransmitters. b. Include half-life and CYP 450 enzyme information. c. List notable side effects. d. Link notable side effects to the associated pathway or neurotransmitter. Provide 7th edition apa references within 5 years. 2 references provided below. Stahl, S. M. (2021a). Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 7th ed. Chamberlain University Press. Stahl, S. M. (2021b). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. In Google Books. Cambridge University Press. **## 3tabledrc.docx** | | | | | | — | — | — | — | | Drug name | **Indication**<br>Target symptoms: state if positive or negative effect<br>Potency (if noted. receptor occupancy if noted ) <br>Neurotransmitter(s) affected | Half-life (T1/2), metabolism (CYP 450 enzyme) | Notable side effects (associate to pathway or NT) | | **Typical antipsychotics (conventional)** | | Haloperidol | | | | | Thioridazine | | | | | Thiothixene | | | | | Fluphenazine | | | | | Mesoridazine | | | | | Chlorpromazine | | | | | **Atypical antipsychotics (2nd generation)** | | **Pines** | | | | | Olanzapine | | | | | Quetiapine | | | | | Asenapine | | | | | Clozapine | | | | | **Dones** | | | | | Risperidone | | | | | Paliperidone | | | | | Ziprasidone | | | | | Iloperidne | | | | | Lurasidone | | | | | **Two Pips and a Rip** | | | | Aripiprazole | | | | | Brexpiprazole | | | | | Cariprazine | | | | 1. For each medication listed, complete the following: a. Provide indication, target symptoms, potency, and affected neurotransmitters. b. Include half-life and CYP 450 enzyme information. c. List notable side effects. d. Link notable side effects to the associated pathway or neurotransmitter. Provide 7th edition apa references within 5 years. 2 references provided below. Stahl, S. M. (2021a). Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 7th ed. Chamberlain University Press. Stahl, S. M. (2021b). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. In Google Books. Cambridge University Press.
